A Genomically Characterized Collection of High-Grade Serous Ovarian Cancer Xenografts for Preclinical Testing
- 1 May 2018
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 188 (5) , 1120-1131
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (CIHR-MOP-191992)
- Canadian Cancer Society Research Institute (020003)
This publication has 53 references indexed in Scilit:
- Xenome—a tool for classifying reads from xenograft samplesBioinformatics, 2012
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Phenotypic heterogeneity and instability of human ovarian tumor-initiating cellsProceedings of the National Academy of Sciences, 2011
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer modelGynecologic Oncology, 2009
- The UCSC Table Browser data retrieval toolNucleic Acids Research, 2004
- The Human Genome Browser at UCSCGenome Research, 2002
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996